Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population

doi:10.1136/bmj.320.7236.671

BMJ 2000;320:671-676 ( 11 March )

Papers

Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population

Editorial by Jackson

Erica J Wallis, research assistant, Lawrence E Ramsay, professor, Iftikhar Ul Haq, research fellow, Parviz Ghahramani, research associate, Peter R Jackson, reader, Karen Rowland-Yeo, non-clinical lecturer, Wilfred W Yeo, senior lecturer.

Clinical Pharmacology and Therapeutics, Royal Hallamshire Hospital, Sheffield S10 2JF

Correspondence to: L E Ramsay d.colley{at}sheffield.ac.uk

Objective: To examine the accuracy of a new version ofthe Sheffield table designed to aid decisions on lipids screeningand detect thresholds for risk of coronary heart disease neededto implement current guidelines for primary prevention of cardiovasculardisease.
Design: Comparison of decisions made on the basisof the table with absolute risk of coronary heart disease or cardiovasculardisease calculated by the Framingham risk function. The decisionsrelated to statin treatment when coronary risk is $>=$ 30% over 10years; aspirin treatment when the risk is $>=$ 15% over 10 years;and the treatment of mild hypertension when the cardiovascularrisk is $>=$ 20% over 10years.
Setting: The table is designed for use in generalpractice.
Subjects: Random sample of 1000 people aged 35-64 yearsfrom the 1995 Scottish healthsurvey.
Main outcome measures: Sensitivity, specificity, and positive andnegative predictive values of thetable.
Results: 13% of people had a coronary risk of $>=$ 15%,and 2.2% a risk of $>=$ 30%, over 10 years. 22% had mild hypertension(systolic blood pressure 140-159 mm Hg). The table indicated lipidsscreening for everyone with a coronary risk of $>=$ 15% over 10 years,for 95% of people with a ratio of total cholesterol to high densitylipoprotein cholesterol of $>=$ 8.0, but for <50% with a coronaryrisk of <5% over 10 years. Sensitivity and specificity were 97%and 95% respectively for a coronary risk of $>=$ 15% over 10 years;82% and 99% for a coronary risk of $>=$ 30% over 10 years; and 88%and 90% for a cardiovascular risk of $>=$ 20% over 10 years in mildhypertension.
Conclusion: The table identifies all high risk peoplefor lipids screening, reduces screening of low risk people bymore than half, and ensures that treatments are prescribed appropriatelyto those at high risk, while avoiding inappropriate treatmentof people at lowrisk.

© BMJ 2000

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Articles

Family history is important in estimating coronary risk: John Younger
BMJ 2000 321: 448. [Extract] [Full Text]

Risk in cardiovascular disease: Richard Neary, Sud Ramachandran, P N Durrington, Daniel Albert, Dougal Jeffries, and P B S Fowler
BMJ 2000 321: 174. [Extract] [Full Text]

New table for assessing coronary risk has high specificity and sensitivity
BMJ 2000 320: 0. [Full Text]

Guidelines on preventing cardiovascular disease in clinical practice: Rodney Jackson
BMJ 2000 320: 659-661. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

Taylor, D R (2009). Risk assessment in asthma and COPD: a potential role for biomarkers?. Thorax 64: 261-264 [Abstract] [Full text]
Taylor, D R, Pavord, I D (2008). Biomarkers in the assessment and management of airways diseases. Postgrad. Med. J. 84: 628-634 [Abstract] [Full text]
van der Steeg, W. A., Boekholdt, S. M., Stein, E. A., El-Harchaoui, K., Stroes, E. S.G., Sandhu, M. S., Wareham, N. J., Jukema, J. W., Luben, R., Zwinderman, A. H., Kastelein, J. J.P., Khaw, K.-T. (2007). Role of the Apolipoprotein B-Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case-Control Analysis in EPIC-Norfolk. ANN INTERN MED 146: 640-648 [Abstract] [Full text]
Burns, G. E. (2005). Challenges of teaching EBM. CMAJ 172: 1423-1424 [Full text]
Ebrahim, S., Montaner, D., Lawlor, D. A (2004). Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysis. BMJ 328: 861- [Abstract] [Full text]
Brindle, P., Emberson, J., Lampe, F., Walker, M., Whincup, P., Fahey, T., Ebrahim, S. (2003). Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327: 1267- [Abstract] [Full text]
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., Fayad, Z., Stone, P. H., Waxman, S., Raggi, P., Madjid, M., Zarrabi, A., Burke, A., Yuan, C., Fitzgerald, P. J., Siscovick, D. S., de Korte, C. L., Aikawa, M., Airaksinen, K. E. J., Assmann, G., Becker, C. R., Chesebro, J. H., Farb, A., Galis, Z. S., Jackson, C., Jang, I.-K., Koenig, W., Lodder, R. A., March, K., Demirovic, J., Navab, M., Priori, S. G., Rekhter, M. D., Bahr, R., Grundy, S. M., Mehran, R., Colombo, A., Boerwinkle, E., Ballantyne, C., Insull, W. Jr, Schwartz, R. S., Vogel, R., Serruys, P. W., Hansson, G. K., Faxon, D. P., Kaul, S., Drexler, H., Greenland, P., Muller, J. E., Virmani, R., Ridker, P. M, Zipes, D. P., Shah, P. K., Willerson, J. T. (2003). From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II. Circulation 108: 1772-1778 [Abstract] [Full text]
Marrugat, J, D'Agostino, R, Sullivan, L, Elosua, R, Wilson, P, Ordovas, J, Solanas, P, Cordon, F, Ramos, R, Sala, J, Masia, R, Kannel, W B (2003). An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J. Epidemiol. Community Health 57: 634-638 [Abstract] [Full text]
Wilson, S, Johnston, A, Robson, J, Poulter, N, Collier, D, Feder, G, Caulfield, M J (2003). Comparison of methods to identify individuals at increased risk of coronary disease from the general population. BMJ 326: 1436- [Abstract] [Full text]
Hense, H.-W., Schulte, H., Lowel, H., Assmann, G., Keil, U. (2003). Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 24: 937-945 [Abstract] [Full text]
Lee, A. (2003). The Need for Integrated Primary Health Care to Enhance the Effectiveness of Health Services. Asia Pac J Public Health 15: 62-67 [Abstract]
Cappuccio, F. P, Oakeshott, P., Strazzullo, P., Kerry, S. M (2002). Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. BMJ 325: 1271-1271 [Abstract] [Full text]
Mehta, J.L., Mascitelli, L., Pezzetta, F., Lauer, M. S. (2002). Aspirin for the Primary Prevention of Coronary Events. NEJM 347: 948-948 [Full text]
Wallis, E. J, Ramsay, L. E, Jackson, P. R (2002). CARDIOVASCULAR AND CORONARY RISK ESTIMATION IN HYPERTENSION MANAGEMENT. Heart 88: 306-312 [Full text]
Whincup, P H, Emberson, J R, Lennon, L, Walker, M, Papacosta, O, Thomson, A (2002). Low prevalence of lipid lowering drug use in older men with established coronary heart disease. Heart 88: 25-29 [Abstract] [Full text]
Rabindranath, K S, Anderson, N R, Gama, R, Holland, M R (2002). Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation. Postgrad. Med. J. 78: 269-272 [Abstract] [Full text]
Lee, A., Mittelmark, M. B. (2002). Health promotion and health education in China: priority area for the IUHPE. Global Health Promotion 9: 6-7
McManus, R J, Mant, J, Meulendijks, C F M, Salter, R A, Pattison, H M, Roalfe, A K, Hobbs, F D R (2002). Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ 324: 459-464 [Abstract] [Full text]
Smellie, W S. A, Lowrie, R., Wilkinson, E. (2001). Quality improvement report: A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care. BMJ 323: 1224-1227 [Abstract] [Full text]
Marchioli, R, Avanzini, F, Barzi, F, Chieffo, C, Di Castelnuovo, A, Franzosi, M.G, Geraci, E, Maggioni, A.P, Marfisi, R.M, Mininni, N, Nicolosi, G.L, Santini, M, Schweiger, C, Tavazzi, L, Tognoni, G, Valagussa, F, on behalf of GISSI-Prevenzione Investigators, (2001). Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart. Eur Heart J 22: 2085-2103 [Abstract]
Wood, D. (2001). Asymptomatic individuals - risk stratification in the prevention of coronary heart disease. Br Med Bull 59: 3-16 [Abstract] [Full text]
Bankhead, C., Emery, J., Qureshi, N., Campbell, H., Austoker, J., Watson, E. (2001). New developments in genetics--knowledge, attitudes and information needs of practice nurses. Fam Pract 18: 475-486 [Abstract] [Full text]
Higgins, M (2001). Patients, families and populations at high risk for coronary heart disease. Eur Heart J 22: 1682-1690
Nair, D.R., Wierzbicki, A.S., Mikhailidis, D.P. (2001). Time to look beyond just lowering the serum concentration of low density lipoprotein - high density lipoprotein levels are also important. The Journal of the Royal Society for the Promotion of Health 121: 98-101 [Abstract]
DURRINGTON, P N, PRAIS, H (2001). Methods for the prediction of coronary heart disease risk. Heart 85: 489-490 [Full text]
(2001). Statin therapy - what now?. DTB 39: 17-21 [Abstract] [Full text]
Sanmuganathan, P S, Ghahramani, P, Jackson, P R, Wallis, E J, Ramsay, L E (2001). Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 85: 265-271 [Abstract] [Full text]
Jones, A F, Walker, J, Jewkes, C, Game, F L, Bartlett, W A, Marshall, T, Bayly, G R (2001). Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 85: 37-43 [Abstract] [Full text]
Hulley, S. B, Grady, D., Browner, W. S (2000). Statins: underused by those who would benefit. BMJ 321: 971-972 [Full text]
Lloyd-Mostyn, R., Cracknell, P., Jolly, K., Rouse, A., Lip, G. Y H (2000). National service framework for coronary heart disease. BMJ 321: 634-634 [Full text]
Younger, J. (2000). Family history is important in estimating coronary risk. BMJ 321: 448-448 [Full text]
Neary, R., Ramachandran, S., Durrington, P N, Albert, D., Jeffries, D., Fowler, P B S (2000). Risk in cardiovascular disease. BMJ 321: 174-174 [Full text]
Wallis, E. J, Ramsay, L. E, Yikona, J. I N M, Jackson, P. R, Isles, C., Ritchie, L. (2000). Comparison of methods of estimating coronary risk. BMJ 321: 175-175 [Full text]
Jackson, R. (2000). Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320: 659-661 [Full text]

Rapid Responses:

Read all Rapid Responses

Table the primary event.: Tom Oommen
bmj.com, 12 Mar 2000 [Full text]
New Sheffield tables: Paul N Durrington
bmj.com, 11 Apr 2000 [Full text]
Importance of family history on risk: John Younger
bmj.com, 18 Apr 2000 [Full text]